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Abstract: The term chitosan (CS) refers to a family of aminopolysaccharides derived from chitin.
Among other properties, CS is nontoxic, mucoadhesive and can be used for load and transport drugs.
Given these and other physicochemical and biological properties, CS is an optimal biopolymer for the
development of transmucosal drug delivery systems, as well as for the treatment of pathologies related
to mucosal dysfunctions. Mucins are glycoprotein macromolecules that are the major components of
mucus overlaying epithelia. CS interacts with mucin and adsorbs on and changes the rheology of
mucus. However, CS and mucins denote families of polymers/macromolecules with highly variable
chemical structure, properties, and behavior. To date, their interactions at the molecular level have
not been completely unraveled. Also, the properties of complexes composed of CS and mucin vary
as a function of the sources and preparation of the polymers. As a consequence, the mucoadhesion
and drug delivery properties of such complexes vary as well. The breadth of this review is on the
molecular interactions between CS and mucin. In particular, in vitro and ex vivo characterization
methods to investigate both the interactions at play during the formation of CS-mucin complexes,
and the advances on the use of CS for transmucosal drug delivery are addressed.
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1. Introduction
Epithelium comprises all the free surfaces of the body—the skin and the surfaces of internal
cavities and tubular organs. The most external layer of the epithelium is called the mucosa. Depending
on its location, the mucosa receives different names, i.e., oral, nasal, anal, gut, or intestinal mucosa.
The exposure of epithelium to the external environment leads to several risks, such as the loss of water
and thus the desiccation of surfaces, or the attack of bacteria, fungi, or viruses. Thus, to protect itself
from risks derived from the exposure to environmental conditions or to pathogens, the more external
layers of cells synthesize and secrete mucus.
2. The Mucus Layer
Mucus is a semipermeable barrier that allows the exchange of water, nutrients, gases, active
biomolecules such as hormones and odorants, and cells such as gametes. However, mucus constitutes
a barrier for most of the pathogens [1]. In this sense, the mucus layer is a first level defence against the
colonisation of the subjacent epithelial cells [2,3].
The structure of the mucus layer on the epithelial surfaces has different regions. In contact with
the subjacent cells through the glycocalyx, there is a layer firmly attached—known as the unstirred
layer—which gives lubricity to the mucosal surfaces (Figure 1). The next region is a mucus blanket,
whose thickness varies as a function of the epithelium in which it is located [1,4,5]. The furthest region
from the cell surface is the lipid monolayer, which is exposed to the free surface [1]. The mucus layer is
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dynamic. Mucus is continuously synthesized, degraded, shed, and digested. These processes have
different rates as a function of the physiological conditions or the action of the microbiota, among other
factors [3,4,6,7].
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Figure 1. Structure of the mucus gel on the epithelial surfaces. Reprinted from [1], with permission 
from Elsevier. 
The structure and composition of mucus determine its properties to a large extent. Mucins are 
the main component of mucus, which are a family of highly glycosylated proteins (>106 Da) [8] 
synthesised by all cells in the surface mucosa and some gastric glands [9]. The functions in which 
mucins are involved are the adhesion of the unstirred layer to the cell surface, the formation of a 
matrix that is a physical barrier in which pathogens and nanomaterials are trapped [1], and the 
viscoelasticity of mucus, among others. The viscoelasticity of mucus varies as a function of the mucin 
properties, mucin content, mucus hydration [1,10], and the environmental conditions, due to the 
electrostatic repulsive forces that appear on the mucins as a result of the negative surface charge of 
mucins at pH > 2 [11]. Mucus can behave as a viscous fluid, which allows motility of the bacteria and 
sperm trapped in it, and as an elasticsemisolid, which cannot be removed from mucosal surfaces. An 
example of the worst case of the latter is in the cystic fibrosis illness [1]. 
There are at least 15 types of mucins, which are classified as cell-associated mucins and gel-
forming mucins depending on their location [2,12].Although cell-associated mucins have a 
transmembrane domain and an SEA (sea-urchin sperm protein, enterokinase, and agrin) domain [1], 
all mucins share the same structural features (Figure 2)—along the linear proteins peptide backbone 
they are highly glycosylated in the central region, while the C-terminal and N-terminal regions 
remain unglycosylated [13]. Mucins show alternative hydrophilic and hydrophobic regions, which 
are essential to the gel formation [9]. The hydrophilic regions of mucins present a varied number of 
PTS (proline (P)–threonine (T)–serine (S)) domains, which are highly O-glycosilated through the T 
and S residues. The glycan portion accounts for 40–80% of the mass in secreted mucins [4]. The size 
of the glycans [14], as well as the composition and the pattern of glycosylation, varies among mucins 
[15,16] and within the same type of mucins [3]. In fact, 1–20 monosaccharides are attached as linear 
or branched polysaccharides through O-glycosidic linkage to mucins [17]. Some glycans have in their 
structure sialic acid, which along with the N-linked sulphate groups, confers a negative charge to the 
mucins at a neutral pH [15,18]. The hydrophobic domains of mucins contain domains similar to the 
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main component of mucus, which are a family of highly glycosylated proteins (>106 Da) [8] synthesised
by all cells in the surface mucosa and some gastric glands [9]. The functions in which mucins are
involved are the adhesion of the unstirred layer to the cell surface, the formation of a matrix that is
a physical barrier in which pathogens and nanomaterials are trapped [1], and the viscoelasticity of
mucus, among others. The viscoelasticity of mucus varies as a function of the mucin properties, mucin
content, mucus hydration [1,10], and the environmental conditions, due to the electrostatic repulsive
forces that appear on the mucins as a result of the negative surface charge of mucins at pH > 2 [11].
Mucu can behave as a viscous fluid, which allo s motility of the bacte ia and sperm trapped in it,
and as an elasticsemisolid, which cannot be removed from mucosal surfaces. An example of the worst
case of the latter is in the cystic fibrosis illness [1].
There are at least 15 types of mucins, which are classified as cell-associated mucins and gel-forming
mucins depending on their location [2,12].Although cell-associated mucins have a transmembrane
domain and an SEA (sea-urchin sperm protein, enterokinase, and agrin) domain [1], all mucins
share the same structural features (Figure 2)—along the linear proteins peptide backbone they are
highly glycosylated in the central region, while the C-terminal and N-terminal regions remain
unglycosylated [13]. Mucins show alternative hydrophilic and hydrophobic regions, which are
essential to the g l formation [9]. The hydrophilic regions of mucins pr sent a varied numb r of PTS
(proline (P)–threonine (T)–serine (S)) domains, which are highly O-gl cosilated through the T and S
residues. The glycan portion accounts for 40–80% of the mass in secreted mucins [4]. The size of the
glycans [14], as well as the composition and the pattern of glycosylation, varies among mucins [15,16]
and within the same type of mucins [3]. In fact, 1–20 monosaccharides are attached as linear or branched
polysaccharides through O-glycosidic linkage to mucins [17]. Some glycans have in their structure
sialic acid, which along with the N-linked sulphate groups, confers a negative charge to the mucins at a
neutral pH [15,18]. The hydrophobic domains of mucins contain domains similar to the von Willerbrand
C and D domains [19,20], which are rich in cysteine and charged aminoacids [2,8]. The hydrophobic
regions establish disulphide bonds between them, leading to the formation of a branched network of
mucins [8,9] (Figure 3). The electrostatic interactions also contribute to the formation of the mucin
gel, due to the interaction between hydrophilic regions [1,8]. By means of high-resolution scattering
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techniques (synchrotron small-angle X-ray scattering (SAXS), small-angle neutron (SAN), dynamic
light scattering (DLS) and static light scattering (SLS)), it has been possible to uncover that mucin
has a cylindrical, double-globular (also known as “dumbbell”) comb macromolecular structure [21].
Therefore, the mucin gel is a dynamic structure that can trap particles within it, thanks to the electrostatic
bonds that are continuously formed between mucins and with any other charged particles within the
mucus. As a result, mucins can form aggregates up to 20 MDa [10].
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Figure 2. The domain structure of mucins. VWD: Von Wiellebrand D-domain, C8: conserved cysteine 
rich domain, TIL: trypsin inhibitor-like cystein-rich domain, CysD: domain rich in cystein residues, 
VWC: Von Wiellebrand C-domain,  PTS: PTS domains, CK: cystein knot domain, NIDO: nidogen 
homology region, AMOP: the adhesion-associated domain in MUC4 and other proteins, SEA: sea-
urchin sperm protein, enterokinase, and agrin domain, TM: transmembrane domain.  Reprinted with 
permission from Springer Nature, Copyright 2016 [2]. 
Figure 2. e o ain structure of mucins. VWD: Von Wiellebrand D-domai , C8: conserved
cysteine rich domain, TIL: trypsin inhibitor-like cystein-rich domain, CysD: domain rich in cystein
residues, VWC: Von Wiellebrand C-domain, PTS: PTS domains, CK: cystein knot domain, NIDO:
nidogen homology region, AMOP: the adhesion-associated domain in MUC4 and other proteins, SEA:
sea-urchin sperm protein, enterokinase, and agrin domain, TM: transmembrane domain. Reprinted
with permission from Springer Nature, Copyright 2016 [2].Biomimetics 2019, 4, 32 4 of 22 
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Figure 3. Representation of the crosslinking of mucins. Extracted with permission from [1]. 
Mucins have gained increasing traction from the biomedical and biotechnological fields, 
particularly in drug delivery, biolubrication, and mucoadhesion areas [13]. Due to the ability of 
mucins to form hydrogels [13] as a function of the environmental conditions, such as pH and ionic 
strength [8,10,19], these glycoproteins are involved in the absorption of water and nutrients and in 
the relationships with bacteria, enhancing the colonisation by symbiotic bacteria and avoiding the 
attachment of pathogenic ones [22]. At a neutral pH, mucins have an isotropic random coil 
conformation that is changed when the pH is decreased. At pH < 4, the conformation of mucins 
corresponds to an anisotropic rod-like structure [8,19], and the interactions between hydrophobic 
regions in mucin macromolecules are facilitated. Moreover, the electrostatic repulsive forces that 
appear as a consequence of the presence of sialic acids, sulfate groups, and negatively charged 
residues in the sequence of the mucins are responsible for maintaining the extended conformation of 
the rod-like structures [10]. Therefore, the gel formation is enhanced. 
The administration of drugs through mucosal epithelia (i.e., oral, nasal, anal, pulmonary, ocular, 
trans vesicular, or vaginal) requires the development of mucoadhesive drug delivery systems. In this 
context, the studies developed with natural and synthetic polymers (which interact with mucins) [13] 
help us to understand the mechanism of mucoadhesion and as a result of this enabling the creation 
of targeted mucosal therapies. 
Chitin is one of the most abundant polysaccharides in nature, with an estimated annual 
production of 10 to 100 trillion of metric tons [23,24]. Chitin can be found in the exoskeleton of 
arthropods, in the fungus of mycelia, and in squid pens, among other sources [25,26]. Chemically, 
chitin is a linear homopolymer composed of N-acetyl-D-glucosamine attached by β(1→4) linkage [27] 
(Figure 4), which can be found in at least two isoforms according to the orientation of the chains, α- 
and β-chitin [28,29]. Chitin is a biocompatible polymer, which shows desirable properties in the 
promotion of wound healing or the suppression of tumorigenic cells [26]. Although it is possible to 
produce biomaterials from chitin, such as hydrogels or nanofibres [23], the use of chitin is limited 
due to its low solubility in aqueous systems. To overcome this drawback, chitin can be deacetylated 
[30–32], yielding a family of polymers that show increased solubility in aqueous solvents. These 
polymers are known with the generic name of chitosan (Figure 4). 
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strength [8,10,19], these glycoproteins are involved in the absorption of water and nutrients and
in the relationships with bacteria, enhancing the colonisation by symbiotic bacteria and avoiding
the attachment of pathogenic ones [22]. At a neutral pH, mucins have an isotropic random coil
conformation that is changed when the pH is decreased. At pH < 4, the conformation of mucins
corresponds to an anisotropic rod-like structure [8,19], and the interactions between hydrophobic
regions in mucin macromolecules are facilitated. Moreover, the electrostatic repulsive forces that
appear as a consequence of the presence of sialic acids, sulfate groups, and negatively charged residues
in the sequence of the mucins are responsible for maintaining the extended conformation of the rod-like
structures [10]. Therefore, the gel formation is enhanced.
The administration of drugs through mucosal epithelia (i.e., oral, nasal, anal, pulmonary, ocular,
trans vesicular, or vaginal) requires the development of mucoadhesive drug delivery systems. In this
context, the studies developed with natural and synthetic polymers (which interact with mucins) [13]
help us to understand the mechanism of mucoadhesion and as a result of this enabling the creation of
targeted mucosal therapies.
Chitin is one of the most abundant polysaccharides in nature, with an estimated annual production
of 10 to 100 trillion of metric tons [23,24]. Chitin can be found in the exoskeleton of arthropods, in the
fungus of mycelia, and in squid pens, among other sources [25,26]. Chemically, chitin is a linear
homopolymer composed of N-acetyl-d-glucosamine attached by β(1→4) linkage [27] (Figure 4), which
can be found in at least two isoforms according to the orientation of the chains, α- and β-chitin [28,29].
Chitin is a biocompatible polymer, which shows desirable properties in the promotion of wound
healing or the suppression of tumorigenic cells [26]. Although it is possible to produce biomaterials
from chitin, such as hydrogels or nanofibres [23], the use of chitin is limited due to its low solubility in
aqueous systems. To overcome this drawback, chitin can be deacetylated [30–32], yielding a family of
polymers that show increased solubility in aqueous solvents. These polymers are known with the
generic name of chitosan (Figure 4).
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Figure 4. Structure of fully N-acetylated chitin (a), fully N-deacetylated chitosan (b) and 
representative partially N-acetylated chitosan sequence (c). 
The chitosan family exhibits a high diversity in its members as a function of the degree (DA) and 
pattern of acetylation (PA) and the degree of polymerisation (DP). DA, PA, and DP are the key factors 
involved in the complex behaviour of chitosan in solution [33,34]. Chitosan dissolves in aqueous 
dilute acidic conditions at a pH lower than ~6.1–6.3, its intrinsic pK0 [35–37], due to the protonation 
of the amino groups and appearance of repulsive electrostatic forces. This also determines the 
stretching of the chains, showing both rigid [38,39] or semiflexible [40,41] conformation as a function 
of the environmental properties as well as of intrinsic features of these biopolymers. As a result, 
chitosan is a polycationic biopolymer in water solution. 
Chitosans are biocompatible and biodegradable polymers that have antimicrobial activity and 
the ability to promote wound healing, among other interesting properties in the biomedical field. 
Another important bioactivity of (chitosan) CS is that it enhances the paracellular transport of active 
molecules [42,43]. This contributes to increasing the permeability of the payload of interest across the 
epithelial barrier [44,45]. Chitosan binds to integrins αvβ3, which are in the membrane of intestinal 
epithelial cells. These integrins activate a signal route that involves focal adhesion kinase (FAK) and 
Src tyrosine kinases, inducing the degradation of the structural proteins of tight junctions in intestinal 
epithelial cells [45]. This activation mechanism induces the reversible opening of the tight junctions, 
thus enhancing the permeability of the drug while enhancing its systemic absorption. Another key 
role of CS is to protect active biomolecules which are transported in the polymeric structure. This fact 
increases the bioavailability of drugs and increases the probability that they reach their target sites. 
There is a lot of interest in the application of CS in the biomedical and pharmaceutical fields due 
to their potential applications, such as drug delivery agent, blood anticoagulant, tissue engineering 
and space fillings material, among others. However to date, the commercial use of CS-based 
treatments are limited to those promoting wound healing and to haemostasis [46,47]. Understanding 
mucoadhesion and the nature of the interactions at play between CS, mucin, and the mucus gel have 
gained traction, particularly with a view to the development of smart drug delivery systems [48]. 
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involved in the complex behaviour of chitosan in solution [33,34]. Chitosan dissolves in aqueous dilute
acidic conditions at a pH lower than ~6.1–6.3, its intrinsic pK0 [35–37], due to the protonation of the
amino groups and appearance of repulsive electrostatic forces. This also determines the stretching
of the chains, showing both rigid [38,39] or semiflexible [40,41] conformation as a function of the
environmental properties as well as of intrinsic features of these biopolymers. As a result, chitosan is a
polycationic biopolymer in water solution.
Chitosans are biocompatible and biodegradable polymers that have antimicrobial activity and
the ability to promote wound healing, among other interesting properties in the biomedical field.
Another important bioactivity of (chitosan) CS is that it enhances the paracellular transport of active
molecules [42,43]. This contributes to increasing the permeability of the payload of interest across the
epithelial barrier [44,45]. Chitosan binds to integrins αvβ3, which are in the membrane of intestinal
epithelial cells. These integrins activate a signal route that involves focal adhesion kinase (FAK) and
Src tyrosine kinases, inducing the degradation of the structural proteins of tight junctions in intestinal
epithelial cells [45]. This activation mechanism induces the reversible opening of the tight junctions,
thus enhancing the permeability of the drug while enhancing its systemic absorption. Another key
role of CS is to protect active biomolecules which are transported in the polymeric structure. This fact
increases the bioavailability of drugs and increases the probability that they reach their target sites.
There is a lot of interest in the application of CS in the biomedical and pharmaceutical fields due to
their potential applications, such as drug delivery agent, blood anticoagulant, tissue engineering and
space fillings material, among others. However to date, the commercial use of CS-based treatments are
limited to those promoting wound healing and to haemostasis [46,47]. Understanding mucoadhesion
and the nature of the interactions at play between CS, mucin, and the mucus gel have gained traction,
particularly with a view to the development of smart drug delivery systems [48].
3. Mucoadhesive Properties of Chitosan
The way in which chitosan and mucin interact determines the behaviour and fate of chitosan
based nanosystems. Thus, the simplest postulation is that these types of biomaterials could be
adsorbed at the mucus layer, shed with the mucus, or go through this layer and reach the cell surface.
However, it could also occur that chitosan containing systems are covered by mucins, impeding their
function (Figure 5). Thus, it is of great importance to study the mucoadhesive properties of chitosan
and chitosan-based nanomaterials. To this end, different biophysical techniques can be used, such
as viscosimetry, small-deformation rheology, microrheology, turbidimetry measurements, ζ-potential
measurements, dynamic light scattering, isothermal titration calorimetry, fluorescence quenching studies,
atomic force microscopy, confocal laser scanning microscopy, and transmission electron microscopy
(TEM) [13,22,49].
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nanosystems achieve the mucus, they can go through the mucus and reach the epithelium (a), be shed 
with the mucus (b) or get trapped in the mucus gel (c). 
Due to the great variability in the composition and structure of chitosan and mucin, there have 
been wealth of studies addressing the interaction between these macromolecules in which different 
raw materials have been used and often the obtained results are contradictory. Concerning mucins, 
since their structure is essentially the same in both types of mucins—secreted and cell-associated—
the behaviour of secreted mucins is expected to be shared by those cell-associated mucins. Therefore, 
the experimental works are typically developed with secreted mucins, which may be typically 
obtained either as a commercial research reagent (e.g., from Sigma-Aldrich, Darmstadt, Germany) 
from various sources (e.g., pig stomach, bovine submaxillary cavity) and degrees of purity or else 
purified directly from excised mucosal tissues. In the first case, the composition is subject to high 
batch-to-batch variability and purity. In the second, the variability is given by both the type of 
mucosal tissue and the method of extraction. In regards to chitosan, the variability is given by the 
degree of acetylation (DA), molecular weight, and pattern of acetylation, whether neutral or salt form. 
Also, the properties of both are greatly affected by the solvent, temperature, and concentration 
(Figure 6). Overall, relatively little attention has been given to the understanding of the underlying 
mechanisms of the interactions between chitosans and mucins, and thus more systematic studies are 
needed using different type of chitosans and mucins. 
Figure 5. Possible scenarios in the interaction of chitosan-based nanosystems and mucins. Once the
nanosystems achieve the mucus, they can go through the mucus and reach the epithelium (a), be shed
with the mucus (b) or get trapped in the mucus gel (c).
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Due to the great variability in the composition and structure of chitosan and mucin, there have
been wealth of studies addressing the interaction between these macromolecules in which different
raw materials have been used and often the obtained results are contradictory. Concerning mucins,
since their structure is essentially the same in both types of mucins—secreted and cell-associated—the
behaviour of secreted mucins is expected to be shared by those cell-associated mucins. Therefore,
the experimental works are typically developed with secreted mucins, which may be typically obtained
either as a commercial research reagent (e.g., from Sigma-Aldrich, Darmstadt, Germany) from various
sources (e.g., pig stomach, bovine submaxillary cavity) and degrees of purity or else purified directly
from excised mucosal tissues. In the first case, the composition is subject to high batch-to-batch
variability and purity. In the second, the variability is given by both the type of mucosal tissue and the
method of extraction. In regards to chitosan, the variability is given by the degree of acetylation (DA),
molecular weight, and pattern of acetylation, whether neutral or salt form. Also, the properties of
both are greatly affected by the solvent, temperature, and concentration (Figure 6). Overall, relatively
little attention has been given to the understanding of the underlying mechanisms of the interactions
between chitosans and mucins, and thus more systematic studies are needed using different type of
chitosans and mucins.Biomimetics 2019, 4, 32 7 of 22 
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Figure 6. Intrinsic and extrinsic features that alter the interactions between chitosan and mucin. 
4. Main Forces Behind the Interaction Between Chitosan and Mucin 
Interactions between chitosan and mucins depend on several intrinsic factors (those associated 
directly with the nature of the polymers, e.g., molecular weight, surface charge, conformation) but 
are also highly dependent on the external or environmental factors where the interaction takes place 
(Figure 6). Some external factors have a direct influence on certain intrinsic factors and therefore also 
modulate the interaction exhibited. 
Concentration is a key factor to be considered when studying the interaction between mucin and 
chitosan. With regard to chitosan, above the so-called critical concentration (c*), the chitosan chains 
overlap and form entangled networks [50,51]. Therefore, the chitosan chains will not be free to 
interact with glycoproteins of mucins. In the case of mucins, due to their physiological functions and 
structure, at high concentrations they are also known to form entangled and gel networks [10]. The 
interaction is dependent on the ratio between both macromolecules in solution. However, to estimate 
the number of charges per average molar residue, it is necessary to first know the composition of the 
constituent residues of the polymer or macromolecule. In the case of chitosan, this is readily available 
from the value of DA. However, this is not the case for mucin, given the complexity of its composition. 
Therefore, to express the composition of CS-mucin complexes the mass ratio is often used instead of 
the molar ratio. 
Another important factor is the pH of the media. Chitosan has, in general, a pK0 around 6.1, 
therefore at pH lower than the pK0 the amine group in the N-acetyl-glucosamine units will be 
protonated, leading to electrostatic repulsion forces between them and therefore favouring a more 
extended conformation of the molecule. When the pH is equal or higher than the pK0, repulsion force 
action ceases and the chains get retracted and insoluble. Mucins, on the other hand, are glycoproteins 
with pI between 2 and 3 [10], therefore in solutions where pH > pI these are charged negatively, 
promoting electrostatic repulsion forces between them and giving rise to a more extended 
conformation of the chain [4,52]. Electrostatic complexation (the interaction between mucins and 
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4. Main Forces Behind the Interaction Between Chitosan and Mucin
Interactions between chitosan and mucins depend on several intrinsic factors (those associated
directly with the nature of the polymers, e.g., molecular weight, surface charge, conformation) but
are also highly dependent on the external or environmental factors where the interaction takes place
(Figure 6). Some external factors have a direct influence on certain intrinsic factors and therefore also
modulate the interaction exhibited.
Concentration is a key factor to be considered when studying the interaction between mucin
and chitosan. With regard to chitosan, above the so-called critical concentration (c*), the chitosan
chains overlap and form entangled networks [50,51]. Therefore, the chitosan chains will not be free
to interact with glycoproteins of mucins. In the case of mucins, due to their physiological functions
and structure, at high concentrations they are also known to form entangled and gel networks [10].
The interaction is dependent on the ratio between both macromolecules in solution. However, to
estimate the number of charges per average molar residue, it is necessary to first know the composition
of the constituent residues of the polymer or macromolecule. In the case of chitosan, this is readily
available from the value of DA. However, this is not the case for mucin, given the complexity of its
composition. Therefore, to express the composition of CS-mucin complexes the mass ratio is often
used instead of the molar ratio.
Another important factor is the pH of the media. Chitosan has, in general, a pK0 around
6.1, therefore at pH lower than the pK0 the amine group in the N-acetyl-glucosamine units will be
protonated, leading to electrostatic repulsion forces between them and therefore favouring a more
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extended conformation of the molecule. When the pH is equal or higher than the pK0, repulsion force
action ceases and the chains get retracted and insoluble. Mucins, on the other hand, are glycoproteins
with pI between 2 and 3 [10], therefore in solutions where pH > pI these are charged negatively,
promoting electrostatic repulsion forces between them and giving rise to a more extended conformation
of the chain [4,52]. Electrostatic complexation (the interaction between mucins and chitosan) is therefore
likely to be favoured at a pH between 2.4 and 6.3.
Chitosan and mucin in aqueous solutions are known to interact predominantly electrostatically,
yielding protein–polysaccharide complexes. Meng-Lund [53] found that interactions between
chitosan and mucins occur in a two-step entropy driven process, which is favoured at a pH of 5.2,
where interactions between molecules are stronger according to the apparent association constants
(Kapp (1st step) = ~1.75 × 106 M−1 and Kapp (2nd step) = ~106 M−1) compared to pH = 6.3 (Kapp (1st
step) = ~5 × 105 M−1 and Kapp (2nd step) = ~2.5 × 105 M−1). The work force of adhesion in each case
was 0.3–0.5 mN and 0.2 mN, respectively (Table 1).
The interaction between CS and mucin is also affected by the chain flexibility of CS, which depends
on the DA of the chain: the higher the DA, the more flexible the chain, due to the absence of electrostatic
repulsion forces on the surface of the chain. Nevertheless, this behaviour is not always observed.
According to the results from Menchichi et al. [22], CS with a chain length smaller than ~360 to ~730
residues shows a semirigid conformation, regardless of the DA of the chain (Table 1). In another work
from our group [48], the intrinsic viscosity of the chitosan was shown to vary as a function of the ionic
strength. A parameter termed degree of coil contraction was defined as the intrinsic viscosity of the
polymer in water divided by the intrinsic viscosity of the polymer in NaCl to analyse the changes in the
conformation of the polymer. The results indicated that the degree of coil contraction varies with the
CS DA: HMC30 < HDP 56 < HDP 1 > HDP 11 = HDP 27 = HMC 15 (for details, see Table 1 and [48]).
The ionic strength of the media influences the interaction between both species. At a high salt
concentration, the condensation of ions in the solution around opposite charges on the surface of the
macromolecules screens electrostatic forces and the macromolecules behave as neutral species. This
means that the chitosan and mucin become effectively uncharged, and consequently the contribution of
electrostatic interactions is offset [50,51]. Menchichi et al. also studied the interaction between porcine
gastric mucin (PGM) and six different types of CS, namely four biomedical grade CS with DA between
1.6 and 56 and Mw in the range of 123 to 265 kDa, and two pharmaceutical grade CS with DA equal to
32.4 or 14.8 and Mw in the range of 17–27.5 kDa. When suspensions of CS and PGM—both with a
relative viscosity ~2.0—were mixed, a reduction in the relative viscosity of the resulting suspensions
was recorded. This was taken as evidence of the heterotypic interaction between both polymers and
was found to be dependent on the PGM weight ratio in suspension, the DA and Mw of CS, and the
ionic strength of the environment. Of note, the reduction on the relative viscosity was higher in
pure water than in 0.1 M NaCl, consistent with the prominent role of electrostatic interactions at play.
Regarding the role of CS’s Mw, the reduction in the viscosity for low molecular weight CS was always
lower in comparison with other CS [22]. Accordingly, the stoichiometric interaction between CS and
PGM depends on the DA of the polyelectrolyte. These studies led to identifying the ‘stoichiometric
point’ as the PGM weight content in which the relative viscosity of the solution had the minimum
value and the ζ-potential was zero. Interestingly, these studies revealed that, unlike what happens
with CS, if more PGM is added to the solution it remains free in the suspension [22]. It is noteworthy
that, unlike the results from Meng-Lund [53], the Isothermal titration calorimetry (ITC) studies carried
out by Menchichi et al. indicated that the CS–PGM interaction at pH 4.5 is a one-step enthalpy-driven
process. This work was carried out at a lower pH, namely 4.5, with low molecular weight chitosan
and a different type of mucin (Table 1). All these differences could be the reasons for the different
results. In the work from Menchichi et al., the PGM showed a slightly higher affinity towards CS of
intermediate DA (DA = 30%), where the Kapp was 4.58 (±1.51) × 104 M, than towards CS of low DA
(DA 15%), whose Kapp was 2.62 (±1.33) × 104 M [22]. These results reveal a lower affinity between
CS and PGM than that reported by Meng-Lund. The heterogeneity in the results obtained reveals
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that further studies are needed to unravel the thermodynamic nature of the reaction between both
macromolecular species. Experiments to find out if mucins behave differently as a function of their
source of isolation or as a function of the way of purification are also needed.
The interaction between mucin and polyanions is reduced when increasing the ionic strength
of the medium. However, the interaction of PGM and CS in conditions of increased ionic strength
remains, and varies as a function of CS’s Mw [22,48]. The experimental works from Menchichi et al.
confirmed that the electrostatic interaction is important but also point out that other mechanisms of
interaction are implicated as well. The hydrophobic interactions between the hydrophobic domains in
mucins and the acetyl groups in chitosan have been proposed.
Dedinaite et al. [54] studied the interaction between CS with DA 15.5 and Mw 150 kDa and
bovine submaxilliary mucins (BSMG) (Table 1) by ellipsometry and atomic force microscopy (AFM).
For that purpose, a suspension of mucin, 0.025 mg/mL in 30 mM NaNO3, was applied on a mica
surface. As a result, the glycoprotein got attached, producing a soft compressible layer, the adsorbed
mucin was 0.5 mg/m2. According to the results of this group, the repulsive forces found in the mucin
layer are higher than expected for the electrical-double layer, and hence the involvement of a steric
contribution was hypothesised. When a solution of CS (0.02 mg/mL in 30 mM NaNO3) was applied,
this polyelectrolyte produced the compaction of the mucin layer, the reduction of repulsive forces
on the surface of layer of mucin, and the formation of dense composites. Washing of the layer with
sodium dodecyl sulphate (SDS) does not result in the removal of CS or mucins. Then, they applied
another layer of mucin and CS, which is considered as a cycle, and again, the layer formed resisted
the washing. However, the repetition of another cycle, the third, yielded a structure which did not
resist the washing and some content was removed when applying the SDS solution. The authors
identified CS as the element that prevents the loss of mucin from the layers, since when the layer is
only composed of mucin, if a solution of SDS is applied, nearly 80% of mucin is removed [54].
In another study using AFM, the interaction between PGM isolated from the stomach of pigs
and CS of DA 1% and Mw 162 kDa or DA 49% and Mw 250 kDa was analysed. In this work, PGM
(0.05 mg/mL) was immobilised on the mica surface, and a solution of CS (0.3 mg/mL) was used to
modify the tip of the cantilever. According to the results, the interaction between PGM and CS was
dependent on the DA of CS and on the solvent properties (Table 1). CS (DA 49%, Mw 250 kDa) showed
an increase in the number of events of interaction with PGM when lowering the pH from 6.9 to 5.5,
namely from 16.5% to 41.8%, respectively. The forces required for dissociation of PGM and CS were
also measured. These forces rounded 0.2 nN, which were significantly lower than those referred to
covalent bonds, which are 1–3 nN [55]. Accordingly, PGM and CS were proposed to interact due to
electrostatic interactions, with hydrogen bonds and hydrophobic interactions playing an important
role as well. The fact that CS with higher DA showed a higher number of interactions reveals the
importance of the hydrophobic interactions between these macromolecules [55]. Another critical factor
to take into account in the studies with AFM is the dilution of the sample, uncovered by the results from
Li et al. (2010), who studied the interaction forces between CS (DA 15% and Mw 150 kDa) and a film of
mucin (commercially available sample from stomach from Wako Chemical Inc., Osaka, Japan). In those
situations, in which the tip of the cantilever was modified with a solution of CS at a concentration
lower than 0.2%, repulsive forces were detected between both surfaces. On the contrary, when the
concentration of the CS solution was higher than 0.2%, attractive forces were reported. These authors
explain these results from the lack of hydrophilicity in the first case, which increased in the second
scenario [56].
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Table 1. Interaction between chitosan and mucins.
Chitosan DA (%) Mw (kDa) C Chitosan(mg/mL) Mucin
C Mucin
(mg/mL) Solvent T (
◦C) Method Ref.
Chitopharm L
Chitopharm M
Chitopharm S
from Cognis SmbH
N/S
500–5000
100–2000
50–1000
0.6
Porcine gastric
mucin type II with
bound sialic acids
1% (Sigma-Aldrich)
0.5
0.0125 M acetic acid at pH 5.2
or 0.016 M
2-(N-morpholino)ethanesulfonic
acid at pH 6.3
25
Complex
coacervation
Isothermal titration
calorimetry
[53]
Chitosan containing
≤1% insoluble
matterfrom Fluka
15.5 150 0.02
Bovine
submaxiliary
mucins (BSMG)
from Sigma
0.025
20 mM NaNO3. The pH was
7.5 for mucin and 4 for
chitosan
N/S
Surface force
measurements
Atomic force
microscopy
[54]
Chitosanfrom
Katakurachikkarin
Co Ltd.
15 150 Attached tothe cantilever
Mucin form
stomach from Wako
Chemical Inc.
Dry film No solvent, the AFM workedin air conditions 25
Atomic force
microscopy [56]
Two
pharmaceutical
grade CS
HMC 15
HMC 30
from Heppe
Medical Chitosan
(HMC) GmbH
14.8
32.4
27.5
17 10
Porcine gastric
mucin type III
(Sigma-Aldrich)
5 20 mM acetate buffer, pH 4.5 25
Microviscosimetry
Isothermal titration
calorimetry
[22]
Four biomedical
grade
HDP 1
HDP 11
HDP 27
HDP 56
from Mathani
chitosan Put. Ptd.
1.6
11
27.5
56
124
122
143
266
HMCs:
3–4
HDPs:
0.3–0.9
8 MilliQ water and 0.1 M NaCl,both of them at pH 4.5 37
Vicosity
measurements [48]
Two types of
chitosan
1
49
162
250
Cantilever
modified with
chitosan
Mucin samples
from cardia and
fundus of pigs
Film, mucin
linked to a
mica surface
25 mM Hepes buffer, 150 mM
NaCl, pH 6.9 and 25 mM
acetate buffer, 150 mM NaCl,
pH 5.5
25 Atomic forcemicroscopy [55]
N/S: not specified.
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As a result of all the above, the interaction between both species is complex and difficult to
understand and predict. It is important to point out that some research works describe that the
interaction of chitosan and mucin in vivo alters the attachment of the biopolymer to the mucosal
surfaces [11]. Thus, the study of the interactions between chitosan and mucin is of the utmost
importance to advance in the knowledge of potential applications of these polymers.
5. Chitosan-Mucin Complexes: Characterisation and Mucoadhesion
Mucoadhesive hydrogels or nanocomposites obtained from the interaction between mucin and CS
can have potential use for controlled and long-term delivery on the mucosal surfaces of biomolecules
loaded inside them. At the same time, the absorption of such molecules and their bioavailability would
be enhanced [57,58]. These systems could also be used in the development of treatments for increasing
the lubrication of the mucosal surfaces in treatments for pathologies such as ulcerous colitis, which
is related to colon cancer. Below are some works which studied the complexes obtained from the
interactions between CS and different types of mucins.
Deacon et al. (2000) studied nanocomposites composed of PGM, isolated by them, and a glutamate
salt of CS with DA 11% (Table 2). The results indicated that the PGM and chitosan molecules were
easily distinguishable. The length of the PGM chains was 0.5 to 4.0 µm with a constant diameter of ca.
16 nm. In the case of the CS chains, their length was equal to 0.70 ± 0.27 µm, with a constant diameter
of approximately 11 nm. The complexes composed of PGM–CS at 0.1 M seemed to be aggregates of the
polymers. Although structures of different sizes can be seen, most of them showed a diameter equal
to 0.70 ± 0.18 µm. The structure formed had no defined boundaries but filaments of PGM radiating
outside the structure were formed, as was confirmed by the measurement of the diameter of the chains.
When the ionic strength was increased, the complexes reduced their size and also a lower number of
complexes were found [59].
Rossi et al. [60] used CS with DA equal to 84% and BSMG and PGM type III to prepare complexes.
The CS and mucins were prepared at a relative viscosity from 1.0 to 1.5, and the complexes were
prepared at a final CS:mucin ratio in the range of 1:0.5 to 1:20 in water and from 1:0.5 to 1:5 in 0.1 M HCl.
The results showed that the stoichiometry of the interaction between CS and BSMG is a function of the
pH of the medium. It is near 1:5 ratio in water and increases to 1:1 ratio in 0.1 M HCl. According to the
authors, the change in the stoichiometry is likely due to the change in the conformation of the polymer,
confirmed by the change in the intrinsic viscosity value between both solvents. The stoichiometry is
also dependent on the type of mucin used. In the case of the PGM, the stoichiometry is close to 1:10 in
water and 1:2 in 0.1 M HCl for the complexes composed of CS–PGM. These authors demonstrated that
the presence of surplus mucin in the solution resulted in the precipitation of the complexes formed
with the CS. In another work by the same research group [61], it was proven that there is a different
rheological behaviour as a function of the CS:PGM ratios. A negative synergism was observed at a
higher polymer ratio. In fact, the value of viscosity was minimum at a ratio CS:PGM 1:0.5 in water and
0.1 M HCl. Interestingly, a positive synergism was reported in conditions of a higher content of mucin
CS:PGM 1:10 in water and 1:5 in 0.1 M HCl.
Complexes composed of CS with DA equal to 19% and Mw 113 kDa and PGM type II (Table 2)
were synthesised by Silva et al. [11]. These complexes were distributed in two populations of
micrometric (2795 ± 247 nm) and nanometric (478 ± 112 nm) size. In this work, the interaction of the
CS, the PGM, and the complexes composed of both macromolecules with Langmuir–Blodgett films of
dimyristoilphosphatidic acid was analysed. The results indicated that the complexes formed interact
with the LB films, either by electrostatic interactions through CS or by hydrophobic interactions via
PGM. Besides this, the interaction between CS and PGM on the membrane is so favoured that if PGM
is adsorbed on the membrane and CS is added, PGM can be removed by interaction with CS.
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Menchicchi et al. [22], as discussed previously, studied the interaction between six different types
of CS of varying DA and Mw and PGM type III (Table 2). Samples of CS and PGM were prepared with
a relative viscosity of approximately 2.0. In the case of PGM, the pH was set to 4.5 and the solvent
conditions were either water or 0.1 M NaCl solution. Then, mixtures of both polymers, CS and PGM,
were prepared at varying mass fractions of mucin (f ), f = 0.2, 0.4, 0.6, and 0.8. Their results showed that,
as the content of PGM fraction in the samples increased, the hydrodynamic diameter of the complexes
containing high Mw CS (DA 1–27%) decreased, while the complexes containing either low or high Mw
CS (DA 56%) did not show any change in size at the different f values. In all cases, an increment in the
size was reported in those conditions of minimum viscosity. Regarding the ζ potential with f for the
complexes formed by the different CS, it was shown that the values at which neutral complexes are
obtained decreases as the DA of CS increases.
Nikogeorgos et al. [13] prepared structures composed of CS (DA 80% and Mw 250 kDa) and PGM
type III (Table 2) at different CS:PGM weight ratios. The results indicated that at pH 3.2, maintaining a
constant concentration of the total polymer in suspension, the ζ potential of the complexes increased
when the content of CS was increased, the same result was reported previously by Menchichi et al. [22].
The electroneutral complexes prepared by Nikogeorgos et al. were formed with a CS weight fraction
equal to 0.33. This value is close to that obtained for complexes with a CS 56% DA at pH 4.5,
synthesised by Menchichi et al., who reported a CS weight fraction equal to 0.3. This similarity, despite
the different DA of the CS, may be due to the different pH values of the solutions (3.2 versus 4.5) used
for each study. Concerning the size of the complexes, a decrease in the size of the final structures
was found when CS was added to a solution of PGM at pH 3.2. It was seen that the higher the CS
content, the lower the hydrodynamic size of the complexes. This behaviour is different from that
reported by Menchichi et al. (2014) [22], who found that complexes composed of CS 56% DA and
Mw similar to that used by Nikogeorgos et al. (2015) [13] in a weight fraction from 0 to 0.4 increased
in size as the CS amount was increased. For higher CS weight fractions, the size of the complexes
diminished as the amount of CS was increased. Due to this, at pH 3.2 the only charged groups in
PGM are the sulphate groups, the interaction between polymers is achieved through the electrostatic
and coulombic interactions between SO−4 in PGM and NH+4 in CS. In the same work, the effect
of the lubricity of these complexes on a membrane of polydimethylsiloxane (PDMS) was studied.
According to the results, the higher the CS weight ratio of the complexes is, the lower the friction
coefficient (µ). The interaction is dependent on the dynamic viscosity, since only the interaction with
the complexes increases the lubricity, while the interaction with PGM or CS does not produce the
same effect. Therefore, the interaction of the polymers to produce the complexes before applying to
the membrane is crucial. According to the friction force microscopy results, the energy needed for
breaking the interaction between the complexes and PDMS membrane is higher than that needed for
breaking the interaction of either PGM or CS with the PDMS membrane. In fact, the higher the CS
weight content is, the higher the energy required. According to the authors, the interaction between
the complexes and PDMS membrane is a process driven by two properties: the net charge of the
complexes and their size. Since the interaction is a diffusion process, the smaller the complexes are,
the more likely the interaction with the PDMS membrane will be.
6. Mucoadhesion of Chitosan-Mucin Complexes
As discussed in the introduction, the mucoadhesion behaviour of the complexes composed by CS
and mucin is important in order to determine the interaction of the complexes with the mucus.
Kootala et al. [62] used CS with a DA lower than 1% and different DPs, namely 8, 52, and 100,
and consequently different Mw (Table 2), and mucin purified from porcine stomach by themselves
and bovine submaxillary mucin glandule (BSMG) to study the interaction of the CS and mucins and
to prepare complexes that were applied on HT29-MTX cell cultures, a cell line that produces mucus.
Mucins were immobilised over layers of polyethylene glycol (PEG) to analyse the interaction with CS.
The results revealed that the lower the DP is, the stronger observed interaction with the mucin, with
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both PGM and BSMG. In this work, it was proven that the immersion of a drop of a solution of CS at
5 mg/mL in a suspension of mucin isolated from porcine stomach resulted in the formation of a hydrogel
composed of CS and mucin. The hydrogels synthesised in this way were analysed by stereomicroscopy,
confocal laser scanning microscopy, and cryo-scanning electron microscopy (CryoSEM). These three
microscopy techniques used in this work allowed us to visualize the hydrogels at different levels of
magnification. The results revealed that CS with lower DP showed a homogeneous distribution of
CS in the hydrogel, and the pore size of these structures was the lowest of the hydrogels synthesised.
Moreover, the hydrogels prepared with CS with DP 52 showed a heterogeneous distribution of CS,
increasing the distribution in the periphery of the structure. In the case of the hydrogel composed of
DP 100, the CS was unable to go inside the structure formed and it was found in the periphery of the
hydrogels. Despite the different disposition of CS on the hydrogels, the amount of CS attached to the
mucin to form the hydrogels was similar in all cases—approximately 0.3 µg of CS per µg of mucin.
The complexation of CS with mucins increased the efficacy of the barrier controlling the diffusion of
particles through it, as can be deduced from the decrease in the diffusion of labelled particles through
the hydrogels. The study of the effect of CS on the mucus layer in HT29-MTX cell culture revealed that
the CS with DP= 8 diffused through all the layers, and the diffusion of small molecules (dextran and
cholera toxin B) fluorescently labelled was not affected. On the contrary, the CS DP 52 and 100 did not
diffuse inside the mucus layer, but formed a sheet on the mucus layer that impaired the diffusion of
particles and small molecules inside the mucus layer.
Szyman´ska et al. [63] prepared different tablets, varying the content of CS with DA in the range of
15 to 25%. The mass ratio in the final formulation ranged from 10 to 40%. The results revealed that
the formulation produced with 40% of CS yielded unstable tablets but those tablets, with a content of
CS between 10 and 30%, were uniform and stable. The mucoadhesion of the tablets was studied on
porcine vaginal mucus. The results showed that the mucoadhesion of the synthesised complexes was
greater as the content of CS increased, indicating that a higher content in CS led to higher work of
adhesion, force detachment, and longer residence time in the mucosa. Other complexes composed of
CS with a DA of 10–25% and Mw of 70–150 kDa were prepared in another work. These complexes
were used to load insulin. The resulting complexes showed a hydrodynamic size of 412 ± 7 nm and a
positive ζ-potential (+36 ± 1 mV), and they were applied to a Caco-2 cell culture and to a co-culture of
Caco-2 and HT29-MTX cells. Unlike HT29-MTX, Caco-2 cells do not produce mucus. The application
of the insulin-loaded NPs increased the intracellular fluorescence in the Caco-2 cell culture, while
the fluorescence in the cells from the co-culture was lower, probably due to the presence of mucus in
the co-culture. Another effect of the presence of mucus was the different level of decrease in the cell
viability produced by the complexes. The decrease was lower in the co-culture cell, the presence of
mucus could be responsible for the protection of the cells [64].
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Table 2. Nanostructures composed of chitosan and mucins.
Chitosan DA (%) Mw (kDa) C Chitosan(mg/mL) Mucin C Mucin (mg/mL) Solvent T (
◦C) Method Ref.
Glutamate salt of
chitosan from Pronova
Ltd. Drammen,
11 N/S N/S Porcine gastric mucin(PGM) isolated by them N/S
0.1 M sodium acetate
buffer, pH 4.5,
0.1 M NaCl. The ionic
strength was
increased up to
0.2 and 0.3 M
N/S
Complexes attached to
mica surfaces and
analised by atomic
force microscopy
performed in air
[59]
Chitosan HCl, high
viscosity grade.
Seacure® CL 313
Pronova Biopolymers
a.s.
84 N/S
0.02–0.08 in
H2O, pH 4.6
0.2–0.8 in
0.1 M HCl, pH 1
Purified mucin from
bovine submaxillary
glands (type I) BSMG
and Partially purified
mucin Pig stomach
type III (sigma)
BSMG: 0.1–0.6 in H2O,
pH 6.8 or
0.4–1.6 in 0.1 M HCl,
pH 1
PGM: 0.4–1.6 in H2O
(pH 4.7–5.1) or 0.1 M
HCl (pH 1)
0.1 M HCl or distilled
water N/S
Viscosity
measurements [60]
Chitosan HCl (high
viscosity grade) (HCS)
Seacure® CL 313.
Pronova Biopolymer
N/S N/S
5–40 in H2O
and 15–50 in
0.1 M HCl
Partially purified
mucin from pig
stomach (Sigma)
7.5–400 in H2O and
10–500 in 0.1 M HCl
0.1 M HCl or distilled
water N/S
Viscosity
measurements and
tensile stress test
[61]
Chitosan from Galena
Farmacêutica 19 113 0.1
Porcine gastric mucin
type II with bound
sialic acids 1% (average
Mw 29 MDa)
0.1 Langmuir monolayer N/S
Fourier transform
infrared spectroscopy
(FTIR) and quartz
crystal microbalance
(QCM)
[11]
Chitosan MMW with a
viscosity near 1%
solution in 1% acetic
acid equals to 200 cP
from Sigma Aldrich
15–25 N/S
Tablets
containing
chitosan
Porcine vaginal mucosa
from large white pigs
weighing ~200 kg
Porcine vaginal mucosa
or 10% mucin gel was
absorbed on a cellulose
fiber
0.08 M acetic buffer,
pH 4.5 37
Measurement of
detachment force and
work of adhesion by
using texture analyser
[63]
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Table 2. Cont.
Chitosan DA (%) Mw (kDa) C Chitosan(mg/mL) Mucin C Mucin (mg/mL) Solvent T (
◦C) Method Ref.
Two pharmaceutical
grade CS
HMC 15
HMC 30
from Heppe Medical
Chitosan (HMC)
GmbH
14.8
32.4
27.5
17
10
Porcine gastric mucin
type III (Sigma) 5
20 mM acetate buffer,
pH 4.5 25
Microviscosimetry
Isothermal titration
calorimetry
[22]
Four biomedical grade
HDP 1
HDP 11
HDP 27
HDP 56
from Mathani Chitosan
Put. Ptd
1.6
11
27.5
56
124
122
143
266
Chitosan Batch
1001135895, from sigma 80 250 0.1
Porcine gastric mucin
type III (Sigma) 0.1
1:1 (v/v) 0.01 M
phosphate buffer
saline (pH 7.4) and
0.01 M HCl. The final
pH was 3.2
RT
ζ-potential, dynamic
light scattering, optical
waveguide light-mode
spectroscopy,
tribometry and
tribopair
[13]
Three chitosans with
DP 8
DP 52
DP 100
from Mahtani chitosan
Ltd. India
<1%
1.3
8.4
16.1
5
Mucin purified from
porcine stomachs. The
mucins isolated were
MUC5A and MUC5B
Commercial bovine
submaxillary mucins
(BSM) from Sigma
Immobilized on a disc
or in solution at
10 mg/mL
Acidified PBS, pH 5.5 25
quartz crystal
microbalance with
dissipation (QCM-D)
and microscopy
[62]
Ultra-pure chitosan
chloride (CS protasan
UP CL 113) from Nova
Matrix
10–25 70–150 1
RevHT29MTX cell line
Adenocarcinoma cell
line Caco-2 from ATCC
In cell culture Water and DMEM 37
Dynamic light
scattering, ζ-potential,
microscopy
[64]
N/S: not specified, RT: room temperature.
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7. Chitosan Cross-linked Structures
The method of preparation of the microspheres influences the final characteristics of the structures,
as was proven in the work of Dhawan et al. [65] (2004). CS with an Mw of 600 kDa was used
to prepare microparticles by different methods, such as thermal gelation, emulsification, and ionic
gelation and cross-linking with Tripolyphosphate (TPP) or glutaraldehyde. The microspheres produced
by thermal gelation (TCL) had the lowest ζ-potential, while the microparticles obtained as a result
of the ionotropic gelation had the highest ζ-potential. In the case of the microparticles chemically
cross-linked, the ζ-potential decreased when the content of the cross-linker in suspension was increased.
The microparticles were immersed in a mucin suspension and the amount of mucin adsorbed to them
was analysed. According to the results, the content of mucin adsorbed was greater as the ζ-potential
of the complexes increased, except for the microparticles obtained through thermal gelation, the
conformation of which should be disrupted during the process. In the case of the ex vivo studies, the
adsorption of the microspheres in the small intestine of rats was analysed. The results indicate that the
adsorption was dependent on the synthesis method of the microspheres. The adhesion was maximum
for those microspheres obtained by ionic gelation. Also, the content of cross-linker was important in
the case of chemically crosslinked microparticles, since the amount of CS adsorbed to the tissue was
higher when decreasing the cross-linking level.
Feng et al. [57] produced nanoparticles composed of CS with DA 11% and Mw 10 kDa and
carboxymethyl chitosan (CMCS) with DA 19% and Mw 12 kDa with 92% of substitution (Table 3). Two
different methodologies were applied, namely ionotropic gelation with TPP (CS/CMCS/TPP) or with
calcium (CS/CMCS/Ca2+). The resulting nanoparticles were loaded with doxorubicin hydrochloride
(DOX, log P 1.27), which shows no attachment to the mucin. According to their results, when applying
the loaded NPs, the content of DOX in the mucin was enhanced. The content of DOX in the mucin
was 1.1–2.1 times higher when applied with CS/CMCS/Ca2+. The ex vivo mucoadhesion was also
analysed, the results showed that the NPs that did not contain TPP had better adhesion. Again,
the mucoadhesion can be described by two steps. First, the intimate contact and wetting of polymers
took place. In the second step, physicochemical interactions yielded the consolidation and strengthen
of the adhesion. In other research work developed with CS with DA lower than 15% and Mw 150 kDa
(Table 3), cross-linked nanoparticles with a ratio TPP:CS equal to 37.5% showed a hydrodynamic
size equal to ≈120 nm and a ζ-potential equal to ≈+30 mV when loaded with insulin. The study on
mucus from jejunum of porcine intestine revealed that nearly 95% of the nanoparticles were retained
in the mucus. Although the effective diffusivity in the mucus was low (0.2 µm2/s), as well as the
mean squared displacement in 2 h (=4 µm2), the evaluation of the efficiency of the systems, developed
through the evaluation of the permeation of the insulin through the intestine, was carried out. To this
end, different segments of rat intestine (jejunum, ileum, and duodenum) were used. The results
indicate that the permeation of the insulin shows a direct correlation with the mucus layer on the
mucosa, with the highest correlation in the jejunum (mucus layer thickness = 123 ± 4 µm), followed
by the duodenum (170 ± 38 µm), and the lowest correlation in the ileum (480 ± 47 µm). With this
experiment, Zhang et al. [66] showed that not only the mucoadhesion is important to achieve the
bioavailability of the drugs transported, but also that the ability of the structures to penetrated the
mucus plays a key role in the permeation efficiency.
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Table 3. Chitosan (CS) nanoparticles crosslinked.
Chitosan DA (%) Mw (kDa) Method ofCrosslinking Mucin
C Mucin
(mg/mL) Solvent T (
◦C) Method Ref.
Chitosan with a viscosity
at 1% in acetic acid 1% at
20 degrees equals to 400
mPa/s from Fluka
N/S 600
Thermal
Glutaraldehyde
Tripolyphosphate,
Emulsification
Ionotropic gelation
Mucin type III partially
purified from porcine
stomach, bound sialic
acids ~1% (Sigma)
0.025–0.5 Milli-Q water RT
Mucus
glycoprotein
assay
[65]
Chitosan from Jinan Hai
debei marine
bioengineering co. Ltd.
≤15 150 Ionotropic gelation
Mucus from jejune
segments of porcine
intestine
Mucus gel Kreb’s-Ringerbuffer 37
Multi particle
tracking and
confocal studies
[66]
CS from Biotech Co. 11 10
Ionic gelation plus
crosslinking with
tripolyphosphate or
calcium
N/S 0.5–2.5
Oxygenated
Kreb’s-Ringer
buffer
37
Mucus
glycoprotein
assay
[57]
Carboxymethyl chitosan
of 92% of substitution
synthesized and
characterized by authors
19 12
N/S: not specified, RT: room temperature.
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8. Conclusions
As discussed in this review, the molecular interaction mechanism between mucin and chitosan
is complex [48]. It depends on the intrinsic properties of both species (mucin and CS) and also on
the environmental conditions (solvent, pH, ionic strength, temperature) of the system in which both
molecules interact. The interaction between the macromolecules occurs mainly due to electrostatic
attraction, hydrogen bonding, and hydrophobic interactions [13,67]. The specific domains implicated
in these interactions have not been completelyuncovered, though it is known that the interactions are
enhanced with the molecular weight and the degree of acetylation of the biopolymer [22,48].
Due to the different properties and behavior of both chitosan and mucin as well as their behaviour
as a function of intrinsic and extrinsic characteristics, it is difficult to find the stoichiometric ratio at
which the macromolecules will interact to produce complexes with potential interest for drug delivery.
Works to date on mucoadhesion of chitosan have revealed that the degree of polymerisation has an
inverse relationship with the bioavailability of drugs loaded in the complexes. As it was discussed here,
the higher the DP, the less homogeneously distributed the complexes in the mucosa are and the lower
the bioavailability of the drugs is. The selection of chitosan as a function of its DA and DP is essential
for the development of drug delivery systems which enable the engineering of stable complexes with
tailored properties such as high levels of mucoadhesion that enhance the bioavailability of the payload.
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